Speaker: 

Anthony Noto, MD, Staff Member, Geisinger - has nothing to disclose.

Mentor: David Ermak

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Identify non-disabling deficits. 
• Learn the risks and benefits of thrombolytic therapy for non-disabling stroke. 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Anthony Noto, MD; Laura Fierke, PA-C and Lisa Wasko, BSN RN SCRN have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.